Latest filing published 03 Jun 2026 for CVRx, Inc..
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Joseph P. Slattery, listed as board member, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Asensus Surgical, Inc., CVRx, Inc. and Morphic Holding, Inc. In total, 75 filings cover trades dated from 4 February 2016 to 1 June 2026.
On the open market, the record shows 8 purchases worth €367k and 21 sales worth €7.0M. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 9 share grants and 36 option exercises.
The median purchase comes to €46k. On 5 out of 7 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 4 purchases show a median change of +78.3%, with the price up in 75% of them. These figures describe past trades and do not predict future prices.
The latest filing, published on 3 June 2026, reports a share grant in CVRx, Inc. The most recent open-market purchase was published on 29 December 2025, 299 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 75 declarations